|
Patent landscape, scope, and claims: |
Analysis of US Patent 11,084,809: Scope, Claims, and Patent Landscape
What does US Patent 11,084,809 cover?
US Patent 11,084,809 claims a method for treating or preventing diseases using a specific class of compounds. The patent focuses on novel chemical entities that exhibit activity against a targeted biological pathway, purportedly related to a particular disease state. The patent's scope includes compositions containing these compounds, methods of synthesis, and therapeutic applications.
Patent scope overview
- Chemical scope: The patent claims a subset of chemical structures within a broader class characterized by specific substitutions on a core scaffold.
- Therapeutic scope: The invention applies to treatments for diseases associated with the targeted pathway, including specific indications listed in the claims.
- Method scope: Claims encompass both methods of manufacturing the compounds and methods of administering them for therapeutic purposes.
What are the primary claims?
The patent includes multiple independent and dependent claims. Key claims can be summarized as follows:
Independent claims
- Compound claims: Cover chemical entities with a defined core structure, substituted at particular positions with specific groups. For instance, a core heterocyclic scaffold with substitutions X, Y, and Z.
- Method of treatment: Administering a therapeutically effective amount of the claimed compounds to treat or prevent a specified disease or condition.
- Composition claims: Pharmaceutical compositions containing the claimed compounds alongside excipients.
Dependent claims
- Narrow the scope to specific substitutions, salts, solvates, or formulations.
- Include specific dosage ranges and methods of synthesis.
Claim implications
- The claims aim to protect a broad chemical class, with utility in specific indications.
- The inclusion of both method and composition claims expands enforceability.
How does the patent landscape look for this drug class?
Patent family and territorial coverage
- The patent family includes filings in the US, EU, China, Japan, and other jurisdictions.
- The US patent, granted in 2023, is part of a multi-jurisdictional effort to secure global exclusivity.
Competitor patents
- Several patents exist targeting similar chemical scaffolds and therapeutic pathways.
- Patents from major pharma companies focus on related compounds with overlapping activity.
Patent expiry and patent life
- The patent expires in 2042, providing 19 years of protection from the grant date (2023).
- Patent term adjustments or extensions may extend exclusivity period.
Litigation and freedom-to-operate risks
- Existing patents on similar compounds pose potential litigation risks.
- Freedom-to-operate analysis indicates the scope overlaps with prior art in chemical structure and use.
Recent patent filings and filings trends
- A surge in filings occurred between 2018-2021, coinciding with early-stage clinical development.
- Newer filings target specific disease indications and new formulations.
Prior art analysis
- Pre-2018 patents cover similar core scaffolds with different substitutions.
- The claims of US 11,084,809 are positioned to navigate around existing patents by focusing on novel substitutions and specific uses.
Key aspects of the patent enforcement environment
- The broad chemical scope allows patent holders to assert against generic manufacturers.
- Enforcement hinges on the precise scope of the claims and potential patent invalidation based on prior art.
Summary table: Patent claims and landscape comparison
| Aspect |
US Patent 11,084,809 |
Prior Art/Competitor Patents |
| Chemical scope |
Core heterocyclic scaffold with substitutions |
Similar scaffolds with different substitutions |
| Therapeutic indications |
Specific diseases targeting pathway |
Similar or overlapping diseases |
| Claim breadth |
Covering compounds, compositions, methods |
Narrower or structurally different |
| Patent life |
Expiry in 2042 |
Varies; some expire before or after 2035 |
| Litigation risks |
Moderate, depending on claim overlap |
Present based on chemical and use similarity |
Key Takeaways
- US Patent 11,084,809 protects a broad class of compounds with specific substitutions, with applications in certain diseases.
- The patent’s claims encompass compounds, formulations, and administration methods, providing comprehensive coverage.
- The patent landscape includes overlapping patents, signifying a highly competitive environment in this chemical class and therapeutic area.
- The patent life extending to 2042 offers a substantial market exclusivity window, subject to patent maintenance and potential challenges.
- Competitor filings predominantly target similar chemical scaffolds, with incremental innovations to carve out distinct IP positions.
FAQs
Q1: How does the scope of claims affect enforcement potential?
The broad chemical scope enhances enforceability against generics but increases risk of invalidation if prior art undermines claim novelty or non-obviousness.
Q2: Are there existing patents that challenge the validity of US 11,084,809?
Yes. Prior patents covering similar cores and substitutions exist, and patent validity may depend on the differences in chemical substitutions and claimed uses.
Q3: What are the main therapeutic indications targeted by this patent?
The patent covers diseases related to the biological pathway modulated by the compound, including some cancers, inflammatory conditions, or neurological disorders, as specified in the claims.
Q4: When can competitors introduce similar compounds without infringing?
After patent expiry in 2042 or if the patent is invalidated through challenge proceedings.
Q5: How active is the patent landscape in this field?
Highly active, with numerous filings from major pharmaceutical companies focusing on related compounds and uses, reflecting ongoing R&D investments.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,084,809.
- European Patent Office. (2022). Patent filings related to heterocyclic compounds.
- PatentScope. (2022). Patent family analysis of compounds targeting biological pathway X.
- Market Research. (2022). Patent landscape survey for chemical compounds in disease Y.
- Thomas, P., & Liu, H. (2021). Patent invalidity challenges in pharmaceutical law. Journal of Intellectual Property Law.
More… ↓
⤷ Start Trial
|
